Search Page

1

Cite

Share

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.

André T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de la Fouchardiere C, Rivera F, Elez E, Bendell J, Le DT, Yoshino T, Van Cutsem E, Yang P, Farooqui MZH, Marinello P, Diaz LA Jr; KEYNOTE-177 Investigators. André T, et al. Among authors: yang p. N Engl J Med. 2020 Dec 3;383(23):2207-2218. doi: 10.1056/NEJMoa2017699. N Engl J Med. 2020. PMID: 33264544 Clinical Trial.

Cite

Share

2

Cite

Share

Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.

Li L, Li X, Xia Y, Chu Y, Zhong H, Li J, Liang P, Bu Y, Zhao R, Liao Y, Yang P, Lu X, Jiang S. Li L, et al. Among authors: yang p. Front Pharmacol. 2020 May 29;11:786. doi: 10.3389/fphar.2020.00786. eCollection 2020. Front Pharmacol. 2020. PMID: 32547394 Free PMC article. Review.

Cite

Share

3

Cite

Share

MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program.

Wang Y, Zhang L, Wu GR, Zhou Q, Yue H, Rao LZ, Yuan T, Mo B, Wang FX, Chen LM, Sun F, Song J, Xiong F, Zhang S, Yu Q, Yang P, Xu Y, Zhao J, Zhang H, Xiong W, Wang CY. Wang Y, et al. Among authors: yang p. Sci Adv. 2021 Jan 1;7(1):eabb6075. doi: 10.1126/sciadv.abb6075. Print 2021 Jan. Sci Adv. 2021. PMID: 33277324 Free PMC article.

Cite

Share

4

Cite

Share

Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.

Andre T, Amonkar M, Norquist JM, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt CJA, Smith D, Garcia-Carbonero R, Sevilla I, De La Fouchardiere C, Rivera F, Elez E, Diaz LA Jr, Yoshino T, Van Cutsem E, Yang P, Farooqui M, Le DT. Andre T, et al. Among authors: yang p. Lancet Oncol. 2021 May;22(5):665-677. doi: 10.1016/S1470-2045(21)00064-4. Epub 2021 Apr 1. Lancet Oncol. 2021. PMID: 33812497 Clinical Trial.

Cite

Share

5

Cite

Share

Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial.

Qin S, Bi F, Gu S, Bai Y, Chen Z, Wang Z, Ying J, Lu Y, Meng Z, Pan H, Yang P, Zhang H, Chen X, Xu A, Cui C, Zhu B, Wu J, Xin X, Wang J, Shan J, Chen J, Zheng Z, Xu L, Wen X, You Z, Ren Z, Liu X, Qiu M, Wu L, Chen F. Qin S, et al. Among authors: yang p. J Clin Oncol. 2021 Sep 20;39(27):3002-3011. doi: 10.1200/JCO.21.00163. Epub 2021 Jun 29. J Clin Oncol. 2021. PMID: 34185551 Clinical Trial.

Cite

Share

6

Cite

Share

A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer.

Jin F, Yang L, Wang W, Yuan N, Zhan S, Yang P, Chen X, Ma T, Wang Y. Jin F, et al. Among authors: yang p. Mol Cancer. 2021 Jul 17;20(1):95. doi: 10.1186/s12943-021-01389-5. Mol Cancer. 2021. PMID: 34273975 Free PMC article. No abstract available.

Cite

Share

7

Cite

Share

The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis.

Luo X, Zheng E, Wei L, Zeng H, Qin H, Zhang X, Liao M, Chen L, Zhao L, Ruan XZ, Yang P, Chen Y. Luo X, et al. Among authors: yang p. Cell Death Dis. 2021 Mar 26;12(4):328. doi: 10.1038/s41419-021-03596-w. Cell Death Dis. 2021. PMID: 33771982 Free PMC article.

Cite

Share

8

Cite

Share

MicroRNA-9 inhibits the proliferation and migration of malignant melanoma cells via targeting sirituin 1.

Bu P, Luo C, He Q, Yang P, Li X, Xu D. Bu P, et al. Among authors: yang p. Exp Ther Med. 2021 Oct;22(4):1135. doi: 10.3892/etm.2021.10569. Epub 2021 Aug 6. Exp Ther Med. 2021. PMID: 34466145 Free PMC article.

Cite

Share

9

Cite

Share

Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis.

Yin C, Li Z, Xiang Y, Peng H, Yang P, Yuan S, Zhang X, Wu Y, Huang M, Li J. Yin C, et al. Among authors: yang p. Front Nutr. 2021 Jul 12;8:709683. doi: 10.3389/fnut.2021.709683. eCollection 2021. Front Nutr. 2021. PMID: 34322514 Free PMC article.

Cite

Share

10

Cite

Share

Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in China.

Cao L, Huang X, Wang N, Wu Z, Zhang C, Gu W, Cong S, Ma J, Wei L, Deng Y, Fang Q, Niu Q, Wang J, Wang Z, Yin Y, Tian J, Tian S, Bi H, Jiang H, Liu X, Lü Y, Sun M, Wu J, Xu E, Chen T, Chen T, Chen X, Li W, Li S, Li Q, Song X, Tang Y, Yang P, Yang Y, Zhang M, Zhang X, Zhang Y, Zhang R, Ouyang Y, Yu J, Hu Q, Ke Q, Yao Y, Zhao Z, Zhao X, Zhao G, Liang F, Cheng N, Han J, Peng R, Chen S, Tang B. Cao L, et al. Among authors: yang p. Transl Neurodegener. 2021 Feb 16;10(1):7. doi: 10.1186/s40035-021-00231-8. Transl Neurodegener. 2021. PMID: 33588936 Free PMC article. Review.

Cite

Share